FMC Corp vs Verisign, Inc. — how do they compare? FMC Corp trades at $8.35 (market cap $1.39B), while Verisign, Inc. trades at $303.74 (market cap $26.92B). The key difference: Verisign, Inc. is far larger — about 19.4× FMC Corp's market cap, and FMC Corp pays the higher dividend (3.59%). Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Verisign, Inc. for 123 Days on average.
| FMC | VRSN | |
|---|---|---|
Market Cap | $1.39B | $26.92B |
Volume | 4,145,979 | 1,921,402 |
Sector | Basic Materials | Technology |
52-Week High | $30.63 | $310.00 |
52-Week Low | $8.35 | $211.49 |
Typical Hold Time | 68 Days | 123 Days |
Enterprise Value | $5.19B | $28.23B |
Dividend Yield | 3.59% | 1.09% |
Signals from Pluang's Aura AI — not financial advice
FMC trades at $8.92, down 1.87% today, reflecting bearish technical signals and weak profitability. The stock shows negative net income margins and ROE, though recent quarterly EPS beat estimates. Cash flow trends are volatile, with 2025 showing negative operational cash flow but positive net cash flow from financing. Analyst consensus is mixed with a near-even split between Buy and Hold ratings, and a price target of $14.60 suggests potential upside. Recent news includes regulatory filings in Brazil and a minority equity investment.
Outlook: FMC faces significant headwinds from declining revenue and negative profitability, but aggressive deleveraging efforts and new product filings offer recovery potential. Risks include high debt, cyclical industry pressures, and execution challenges. The stock may appeal to value investors given low P/S and P/B ratios, but sustained earnings improvement is critical for long-term upside.
VeriSign (VRSN) trades at $297.79, up 1.21% today, with a bullish technical signal and strong institutional interest. The company reported Q2 2026 EPS of $2.38, missing estimates, but maintains robust fundamentals with a 49.77% net income margin and $1.66B revenue in 2025. Recent news includes an upcoming Q3 earnings call and insider sales by the CEO, while an antitrust lawsuit poses a regulatory overhang.
The outlook remains positive with a consensus price target of $348, implying 17% upside, supported by steady cash flow growth and domain registration strength. Key risks include legal challenges and competitive pressures, but analyst sentiment is predominantly bullish with 60% buy ratings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →